Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Recruiting 2Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Breast 1

Conditions

Prostatic Neoplasms 11Leukemia, Myeloid, Acute 10Lung Neoplasms 9Myelodysplastic Syndromes 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 5Multiple Myeloma 5Leukemia, Myelomonocytic, Chronic 5Carcinoma, Non-Small-Cell Lung 5Leukemia, Biphenotypic, Acute 4Colorectal Neoplasms 4Carcinoma, Hepatocellular 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Pancreatic Neoplasms 3Osteosarcoma 3Mouth Neoplasms 3Lymphoma, T-Cell 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Wilms Tumor 2Thyroid Cancer, Papillary 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Myeloproliferative Disorders 2Mycosis Fungoides 2Melanoma 2

Interventions

pembrolizumab 26Cisplatin 17Radiotherapy 13Carboplatin 13Blood Specimen Collection 10Cetuximab 9Docetaxel 8Paclitaxel 7Fluorouracil 7Drug Therapy 7toripalimab 5tislelizumab 4nimotuzumab 4atezolizumab 4Surveys and Questionnaires 4Radiation 4Chemoradiotherapy 4Surgical Procedures, Operative 3Radiotherapy, Intensity-Modulated 3Biopsy 3130-nm albumin-bound paclitaxel 3fludarabine 2cemiplimab 2avelumab 2X-Rays 2Tocopherols 2Tiragolumab 2Therapeutics 2Tablets 2Standard of Care 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Head and Neck Neoplasms × X-Rays × Clear all
NCT06997068 2026-05-11

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Mayo Clinic

Phase 2 Recruiting
25 enrolled
Head & Neck

Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07020117 2026-04-21

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Aktis Oncology, Inc.

Phase 1 Recruiting
150 enrolled
BreastHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡